Jam

Argo Gold Inc. has launched a 60-day digital marketing campaign to boost its market visibility. Partnering with 1001103323 Ontario Inc., the company will utilize X, Facebook, YouTube, and Reddit to reach a wider audience. This strategic move, costing CAD $20,000 initially, aims to enhance investor relations and communicate its dual focus on mineral exploration and oil production through targeted online content.

France’s upcoming ban on social media for under-15s in 2026 is shifting youth advertising to mobile games. Kidoz, an AdTech platform, highlights games as a privacy-compliant, brand-safe alternative. Their contextual advertising model avoids personal data collection, aligning with regulations like COPPA and GDPR-K. This trend signifies a move towards responsible, data-light engagement with younger demographics, driven by both regulation and growing gaming habits.

Elemental Royalty will present its latest investor deck at Renmark’s Virtual Non-Deal Roadshow on January 26, 2026, at 12 PM EST. CEOs David M. Cole and Frederick Bell will discuss the company’s strategy, diversified portfolio of 16 producing assets and over 200 royalties, and growth plans. A Q&A session will follow. Investors can register for the live event or access a replay online.

Itaú Unibanco will release its 4Q25 and full-year 2025 earnings on February 4, 2026. An interactive investor call, in both Portuguese and English, will follow on February 5, 2026. Executives including CEO Milton Maluhy and CFO Gabriel Amado de Moura will discuss performance, strategy, and outlook. Investors can register and access materials on the Investor Relations website. The call will offer insights into credit growth, digital transformation, and macroeconomic trends.

Shell continues its share repurchase program, announcing further share buybacks for cancellation on January 19, 2026. The energy giant acquired shares on the London Stock Exchange and Euronext Amsterdam, managed by Merrill Lynch International. This strategy aims to enhance shareholder value by reducing outstanding shares, boosting earnings per share, and signaling confidence in the company’s future. The program adheres to strict UK and EU regulations, ensuring market integrity and transparency.

Ferrari is significantly increasing its share buyback program, aiming to return approximately €3.5 billion by 2030. Recent purchases totaling €26.58 million highlight the company’s confidence in future growth and its commitment to enhancing shareholder value through higher Earnings Per Share and a strong signal of its stock being undervalued. This strategy also helps manage dilution from employee stock plans.

Marvion Inc. has secured $200,000 in funding through a stock purchase agreement with Ray Mak Pak Fai. This investment will bolster Marvion’s logistics operations and market expansion, focusing on enhancing operational efficiency, increasing warehousing capacity, and supporting strategic initiatives. The capital aims to capitalize on opportunities within the dynamic Hong Kong market.

Montage Gold is on track for its first gold pour at the Koné project in Côte d’Ivoire by late Q4 2026, with construction ahead of schedule. The company has logged over 7.2 million construction hours, with a workforce of over 3,000, predominantly local hires. Significant progress includes the erection of all CIL tanks and early completion of the Tailings Storage Facility. An ambitious $16 million exploration program for 2026 aims to expand resources and test new targets.

Europe’s technology services market achieved a record high in Q4 2025, with demand for AI and cloud services driving significant growth. The combined market for managed services and as-a-service offerings reached $10.9 billion, a 27% year-over-year increase. This strong performance, particularly in cloud-based services and engineering related to AI, signals increased confidence for 2026, despite some industry and regional variations.

Genflow Biosciences appoints seasoned biotech leader Gad Berdugo as Chairman to accelerate its gene therapy pipeline for age-related diseases. Berdugo’s expertise in RNA-LNP therapeutics and U.S. market expansion is expected to drive strategic growth. Key data readouts in 2026 will be critical under his guidance, with Tamara Joseph continuing on the board for continuity.